Health Condition 1: J969- Respiratory failure, unspecified
Conditions
Interventions
Intervention1: Ayurvedic Therapy: Tablet Pure Ashwagandha 500mg BD, Oral, After Breakfast / Dinner
Tablet Pure Giloy Extract 1000 mg BD, Oral, after Breakfast / Dinner
Tablet Pure Tulsi Extract 500
Sponsors
Patanjali Research Institute
National Institute of Medical Sciences Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: Asymptomatic patients Mildly symptomatic patients Moderately symptomatic patients Age 15-80 years of age Patients able to give Informed consent and follow instructions Agree to follow at 14 days and 30 days after testing positive for COVID-19
Exclusion criteria
Exclusion criteria: Severely symptomatic patients (SaO2 Acute Respiratory Distress Syndrome (ARDS) Life expectancy less than 1 year due to other co-morbid conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Virological Clearance as measured by RT PCR of nasopharyngeal swabTimepoint: Baseline, 3 Days, 7 Days, 14 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| Conversion from Symptomatic to Asymptomatic patient Reduction in C-reactive protein, ESR & IL-6 Improvement in heamatological parameters eg Total Leucocyte count Safety analysisTimepoint: Baseline, 3 Days, 7 Days, 14 Days | — |
Countries
India
Contacts
Public ContactDr Abhishek Sharma
National Institute of Medical Sciences
Outcome results
None listed